Clinical trial

Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either…

NCT00014586 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Terminated

Key facts

NCT number NCT00014586
Title Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate Cancer
Official title Randomized Phase III Step-Up Study On Initial Antiandrogen Monotherapy In Comparison With Watchful Waiting In Asymptomatic T1-3 Any G (Any Gleason) NO or Nx M0 Prostate Cancer Patients Without Local Treatment With Curative Intent
Lead sponsor European Organisation for Research and Treatment of Cancer - EORTC, Other
Status Terminated
Phase Phase 3
Study type Interventional
Conditions Prostate Cancer
Intervention type Drug, Procedure
Interventions bicalutamide, goserelin acetate, orchiectomy
Enrollment 110
Start date Jan 1, 2001
Primary completion Feb 1, 2003
First posted Jan 27, 2003
Last update posted Sep 24, 2012
Countries Germany

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies